Journal Study
Population Testing for BRCA1/2 Appears Cost-Effective in Younger Canadian Women
Using simulated data for 1 million women, researchers found that population-based BRCA1/2 testing would be cost-effective, particularly in 30-year-old women.
New Blood Test Shows 90 Percent Accuracy in Diagnosing Alzheimer’s Disease
Developed by researchers from Lund University in Sweden, the test is more accurate than doctors’ diagnoses using standard clinical evaluation tools.
Tumor Gene Expression Signature Linked to Chemotherapy Response in Colon Cancer Cases
Based on hundreds of stage II and III colon cancer samples, researchers uncovered and validated a 10-gene signature linked to adjuvant chemotherapy response.
NGS Tumor Testing Gaps Persist in Metastatic Prostate, Urothelial Cancers
A retrospective health record analysis revealed an inconsistent rise in rates of next-generation sequencing testing in metastatic prostate cancer and advanced urothelial cancer.
Gene Therapy for Ultra-Rare Genetic Condition Shows Promise in Single-Participant Clinical Trial
A Phase I clinical trial of one affected child suggests a gene replacement therapy is a safe and potentially effective treatment for spastic paraplegia type 50.